These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10542974)

  • 1. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma.
    Heinig JH; Boulet LP; Croonenborghs L; Möllers MJ
    Respir Med; 1999 Sep; 93(9):613-20. PubMed ID: 10542974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
    Ringdal N; Chuchalin A; Chovan L; Tudoric N; Maggi E; Whitehead PJ;
    Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
    Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
    J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
    Ayres JG; Bateman ED; Lundbäck B; Harris TA
    Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
    Worth H; Muir JF; Pieters WR
    Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
    Boe J; Bakke P; Rødølen T; Skovlund E; Gulsvik A
    Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
    Kuna P; Joubert JR; Greefhorst LA; Magnussen H
    Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
    Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
    Barnes NC; Hallett C; Harris TA
    Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
    Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
    Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation.
    Ringdal N; Swinburn P; Backman R; Plaschke P; Sips AP; Kjaersgaard P; Bratten G; Harris TA
    Mediators Inflamm; 1996; 5(5):382-9. PubMed ID: 18475734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
    Karakoç F; Karadag B; Kut A; Ersu R; Bakaç S; Cebeci D; Dagli E
    J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.